{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:07:25Z","timestamp":1792166845208,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.spen.2015.10.007","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T18:00:12Z","timestamp":1446487212000},"page":"234-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Advances in Molecular Diagnosis of Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"22","author":[{"given":"Ben","family":"Shofty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Constantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay","family":"Ben-Shachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2015.10.007_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.spen.2015.10.007_bib2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2015.10.007_bib3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ejhg.2008.134","article-title":"Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient","volume":"16","author":"Pasmant","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib4","first-page":"575","article-title":"NIH Consensus Development Conference. Neurofibromatosis. Conference statement","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2015.10.007_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"issue":"Pt 6","key":"10.1016\/j.spen.2015.10.007_bib6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","article-title":"Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales","volume":"111","author":"Huson","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.spen.2015.10.007_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2015.10.007_bib8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/WNL.54.8.1646","article-title":"Use of unidentified bright objects on MRI for diagnosis of neurofibromatosis 1 in children","volume":"54","author":"DeBella","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2015.10.007_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2015.10.007_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.spen.2015.10.007_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.spen.2015.10.007_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00639.x","article-title":"Neurofibromin: A general outlook","volume":"70","author":"Trovo-Marqui","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: From genotype to phenotype","volume":"49","author":"Pasmant","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib14","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1136\/jmg.40.6.e82","article-title":"Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients","volume":"40","author":"Ars","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/9.2.237","article-title":"Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1","volume":"9","author":"Ars","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib16","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2009.1663","article-title":"Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome","volume":"302","author":"Messiaen","year":"2009","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.spen.2015.10.007_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: Statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2015.10.007_bib18","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/sj.onc.1202829","article-title":"Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation","volume":"18","author":"Gutmann","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.spen.2015.10.007_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1471-2164-11-194","article-title":"Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiency","volume":"11","author":"Pemov","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.spen.2015.10.007_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/515504","article-title":"Confirmation of a double-hit model for the NF1 gene in benign neurofibromas","volume":"61","author":"Serra","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib21","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/MCB.22.14.5100-5113.2002","article-title":"Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation","volume":"22","author":"Bajenaru","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.spen.2015.10.007_bib22","first-page":"8573","article-title":"Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity","volume":"63","author":"Bajenaru","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.spen.2015.10.007_bib23","first-page":"305","article-title":"An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes","volume":"53","author":"Easton","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gepi.1129","article-title":"Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1)","volume":"23","author":"Szudek","year":"2002","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.spen.2015.10.007_bib25","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/ddp212","article-title":"Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1","volume":"18","author":"Sabbagh","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.pediatrneurol.2013.02.004","article-title":"Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1","volume":"48","author":"Ko","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.007_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N","article-title":"Do NF1 gene deletions result in a characteristic phenotype","volume":"73","author":"Tonsgard","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmg.2009.075937","article-title":"Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions","volume":"47","author":"Mautner","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/ng2083","article-title":"Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth","volume":"39","author":"Douglas","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib30","first-page":"3021","article-title":"NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies","volume":"34","author":"Ponti","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.spen.2015.10.007_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/jmg.2010.081760","article-title":"A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations","volume":"48","author":"Sharif","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4149\/neo_2013_084","article-title":"Clustering of mutations in the 5\u2032 tertile of the NF1 gene in Slovakia patients with optic pathway glioma","volume":"60","author":"Bolcekova","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.spen.2015.10.007_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib34","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ejhg.2014.243","article-title":"p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas","volume":"23","author":"Pinna","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib35","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: Genotype-phenotype correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Hum Mutat (in press)"},{"key":"10.1016\/j.spen.2015.10.007_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jmg.40.5.368","article-title":"NF1 mutations and clinical spectrum in patients with spinal neurofibromas","volume":"40","author":"Kluwe","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/sj.ejhg.5200807","article-title":"A patient severely affected by spinal neurofibromas carries a recurrent splice site mutation in the NF1 gene","volume":"10","author":"Wimmer","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ejhg.2012.221","article-title":"Increased rate of missense\/in-frame mutations in individuals with NF1-related pulmonary stenosis: A novel genotype-phenotype correlation","volume":"21","author":"Ben-Shachar","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.007_bib39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2015.10.007_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/humu.21418","article-title":"Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1)","volume":"32","author":"Messiaen","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2015.10.007_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.0022-202X.2005.23834.x","article-title":"Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1","volume":"125","author":"Consoli","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.spen.2015.10.007_bib42","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/humu.22152","article-title":"Review and update of SPRED1 mutations causing Legius syndrome","volume":"33","author":"Brems","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2015.10.007_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/molehr\/gah170","article-title":"Preimplantation genetic diagnosis for neurofibromatosis type 1","volume":"11","author":"Spits","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.spen.2015.10.007_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tjog.2011.01.040","article-title":"Successful application of the strategy of blastocyst biopsy, vitrification, whole genome amplification, and thawed embryo transfer for preimplantation genetic diagnosis of neurofibromatosis type 1","volume":"50","author":"Chen","year":"2011","journal-title":"Taiwan J Obstet Gynecol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909115000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909115000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:37:21Z","timestamp":1761028641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909115000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1071909115000741"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2015.10.007","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Molecular Diagnosis of Neurofibromatosis Type 1","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2015.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}